Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
122.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.50 (2.066%)
Market Cap: £194.77m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Board Changes

1 Nov 2024 07:00

RNS Number : 4424K
Redcentric PLC
01 November 2024
 

Redcentric plc

 

("Redcentric" or the "Group")

 

Board Changes

Redcentric plc (AIM: RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, confirms that further to the announcement on 24 September 2024, John Radziwill has been appointed as non-executive director of the Company after completing the relevant due diligence as part of the onboarding process for all new board appointments. Mr Radziwill joins the board as a representative of ND Capital Investments Limited ("ND Capital"), one of the Company's largest shareholders, and is a highly experienced director. Mr Radziwill has held several senior leadership roles in investment banking, advisory and asset management.

Relationship Agreement

In conjunction with Mr Radziwill's appointment, the Company has entered into a relationship agreement with ND Capital. The key terms of this agreement are as follows:

· ND Capital has the right to nominate one person for appointment as a director of the Company providing that ND Capital (together with its individual partners and their affiliates), directly or indirectly, holds no less than 15 per cent of the voting rights of the Company (or 7.5 per cent taking into account any reduction in voting rights resulting from any dilution following the date of the agreement);

· All transactions, agreements or arrangements entered into between a member of the Group and ND Capital and/or any of its associates will be conducted at arm's length and on arm's length commercial terms; 

· ND Capital shall exercise its voting rights to ensure, so far as it is able to do so by the exercise of such rights, that directors independent of ND Capital shall at all times constitute a majority of the Redcentric board (save with the approval of a majority of the independent directors);

· ND Capital and its associates will not propose any resolution or other action to cancel the trading of the Company's shares from trading on AIM without the board's approval (save with the approval of a majority of the independent directors); and

· ND Capital and its associates will not solicit proxies unless consistent with the recommendation of the board, exercise powers to requisition a shareholders' meeting, or undertake any action to obtain or consolidate control of the Company or seek to do so, otherwise than in accordance with the Takeover Code.

Richard McGuire, Chair of Redcentric, commented:

"John brings a wealth of expertise and experience to the Group. His addition further strengthens the Board composition and capabilities to drive execution of the Group's strategic initiatives. John represents one of the Company's long-standing and major investors through his role at ND Capital, and we look forward to his valuable insights and contributions in advancing Redcentric's strategy."

Additional information with regard to John Radziwill:

The following information is disclosed in accordance with Schedule 2(g) of the AIM Rules for Companies:

Full name: John Stanislas Albert Radziwill

Age: 77

Current directorships:

StoneX Group Inc.

Oryx International Growth Fund Ltd.

Seatboost Inc.

GGH Management 2 Sp. z o. o.

GGH Management 3 Sp z o.o.

StoneX Switzerland SA

Netsurion LLC (formerly known as VendorSafe Technologies Inc.)

Furnari Sp.z.o.o.

Previous directorships held in the past 5 years:

GGH MT Sp. z o. o.

Fifth Street Capital (BVI)

 

Save as set out above there are no further disclosures required pursuant to Rule 17 or Schedule Two, paragraph (g) of the AIM Rules for Companies.

Enquiries:

Redcentric plc +44 (0)800 983 2522

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

 

Cavendish Capital Markets Limited - Nomad and Sole Broker +44 (0)20 7220 0500

Marc Milmo / Callum Davidson / Rory Sale (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZMFGMMDGDZM
Date   Source Headline
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSDirectorate Change
22nd Nov 20237:00 amRNSHalf Year Results
20th Oct 20231:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSExercise of Options
3rd Oct 20237:00 amRNSSave As You Earn Share Option Scheme
28th Sep 20234:00 pmRNSResult of AGM
20th Sep 20234:08 pmRNSGrant of Options and Director/PDMR Shareholding
4th Sep 20237:00 amRNSPublication of Annual Report and Notice of AGM
24th Aug 20237:00 amRNSPreliminary results announcement FY23
17th Aug 20237:00 amRNSNotice of Results
17th Jul 20237:00 amRNSUpdate on Annual Results
28th Apr 20235:08 pmRNSHolding(s) in Company
25th Apr 20237:01 amRNSDirectorate Change
25th Apr 20237:00 amRNSTrading Update
31st Mar 20233:14 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSExercise of Options
8th Feb 20237:00 amRNSExercise of Options
11th Jan 20237:00 amRNSExercise of Options
30th Dec 20227:00 amRNSExercise of Options
12th Dec 20227:00 amRNSExercise of Options
8th Dec 20227:00 amRNSHalf Year Results
29th Nov 20223:09 pmRNSHolding(s) in Company
17th Nov 20222:46 pmRNSHolding(s) in Company
15th Nov 20227:00 amRNSTrading Update
2nd Nov 20227:00 amRNSExercise of Options
26th Oct 20227:00 amRNSExercise of Options
19th Oct 20227:00 amRNSExercise of Options
13th Oct 20222:06 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSGrant of Options and Director/PDMR Shareholding
5th Oct 202210:57 amRNSHolding(s) in Company
5th Oct 20227:00 amRNSExercise of Options
16th Sep 202212:36 pmRNSHolding(s) in Company
15th Sep 202212:54 pmRNSHolding(s) in Company
15th Sep 202212:25 pmRNSExercise of Options and PDMR Shareholding
14th Sep 20227:00 amRNSExercise of Options
13th Sep 202211:52 amRNSHolding(s) in Company
7th Sep 20224:28 pmRNSResult of AGM
6th Sep 20227:00 amRNSExercise of Options
5th Sep 20221:53 pmRNSHolding(s) in Company
30th Aug 20227:00 amRNSSave As You Earn Share Option Scheme
30th Aug 20227:00 amRNSExercise of Options
23rd Aug 20229:23 amRNSExercise of Options
17th Aug 20227:00 amRNSExercise of Options
8th Aug 20227:00 amRNSPublication of Annual Report and Notice of AGM
1st Aug 202212:10 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSExercise of Options
22nd Jul 202212:08 pmRNSHolding(s) in Company
21st Jul 20227:01 amRNSAlan Aubrey - AIM Rule 17 Disclosures
21st Jul 20227:00 amRNSPreliminary results announcement FY22

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.